Cargando…
FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition
Cancer cells with stem cell properties (CSCs) underpin the chemotherapy resistance and high therapeutic failure of triple-negative breast cancers (TNBCs). Even though CSCs are known to proliferate more slowly, they are sensitive to inhibitors of G2/M kinases such as polo-like kinase 1 (PLK1). Unders...
Autores principales: | Pietilä, Mika, Vijay, Geraldine V., Soundararajan, Rama, Yu, Xian, Symmans, William F., Sphyris, Nathalie, Mani, Sendurai A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827390/ https://www.ncbi.nlm.nih.gov/pubmed/27064522 http://dx.doi.org/10.1038/srep23070 |
Ejemplares similares
-
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
por: Paranjape, A N, et al.
Publicado: (2016) -
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
por: Vijay, Geraldine Vidhya, et al.
Publicado: (2019) -
The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition
por: Taube, Joseph H., et al.
Publicado: (2017) -
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression
por: May, Caitlin D, et al.
Publicado: (2011) -
GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)